Organization
Unicycive Therapeutics
1 clinical trial
Clinical trial
A Multicenter, Multidose, Study to Assess the Tolerability and Pharmacokinetics of Oxylanthanum Carbonate at Clinically Effective Doses in Patients With Chronic Kidney Disease on DialysisStatus: Active (not recruiting), Estimated PCD: 2024-03-31